Trial intelligence / Profile preview

Fluticasone Propionate Nasal Spray for Ocular Symptoms in Seasonal Allergic Rhinitis

NCT01817790Phase 3Completed

Sponsor
GSK
Start
Dec 2012
Primary completion
Feb 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Dec 2012; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT01817790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01817790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call